SG11201605825WA - Stable compositions of peptide epoxy ketones - Google Patents
Stable compositions of peptide epoxy ketonesInfo
- Publication number
- SG11201605825WA SG11201605825WA SG11201605825WA SG11201605825WA SG11201605825WA SG 11201605825W A SG11201605825W A SG 11201605825WA SG 11201605825W A SG11201605825W A SG 11201605825WA SG 11201605825W A SG11201605825W A SG 11201605825WA SG 11201605825W A SG11201605825W A SG 11201605825WA
- Authority
- SG
- Singapore
- Prior art keywords
- stable compositions
- peptide epoxy
- epoxy ketones
- ketones
- peptide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14/023,247 US9636376B2 (en) | 2012-09-11 | 2013-09-10 | Stable compositions of peptide epoxy ketones |
| PCT/US2014/054283 WO2015038431A1 (en) | 2013-09-10 | 2014-09-05 | Stable compositions of peptide epoxy ketones |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201605825WA true SG11201605825WA (en) | 2016-09-29 |
Family
ID=50233867
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201902826PA SG10201902826PA (en) | 2013-09-10 | 2014-09-05 | Stable compositions of peptide epoxy ketones |
| SG11201605825WA SG11201605825WA (en) | 2013-09-10 | 2014-09-05 | Stable compositions of peptide epoxy ketones |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201902826PA SG10201902826PA (en) | 2013-09-10 | 2014-09-05 | Stable compositions of peptide epoxy ketones |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US9636376B2 (en) |
| EP (1) | EP3062883A4 (en) |
| CA (1) | CA2934859A1 (en) |
| EA (1) | EA201691358A1 (en) |
| SG (2) | SG10201902826PA (en) |
| WO (1) | WO2015038431A1 (en) |
| ZA (1) | ZA201604055B (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015198257A1 (en) * | 2014-06-26 | 2015-12-30 | Intas Pharmaceuticals Ltd. | Stable carfilzomib injection |
| WO2016110870A1 (en) * | 2015-01-07 | 2016-07-14 | Emcure Pharmaceuticals Limited | Pharmaceutical composition of bortezomid |
| WO2016116882A2 (en) * | 2015-01-23 | 2016-07-28 | Leiutis Pharmaceuticals Pvt Ltd | Novel compositions of carfilzomib |
| WO2016170489A1 (en) * | 2015-04-24 | 2016-10-27 | Fresenius Kabi Oncology Ltd. | Pharmaceutical compositions of proteasome inhibitor |
| US10098890B2 (en) | 2016-10-29 | 2018-10-16 | Cipla Limited | Stable carfilzomib formulations |
| US11224631B2 (en) | 2017-01-24 | 2022-01-18 | Orbicular Pharmaceutical Technologies Pvt. Ltd. | Ready-to-use Carfilzomib compositions |
| GB2562270B (en) * | 2017-05-10 | 2020-07-01 | Hyphens Pharma Pte Ltd | Skin barrier composition |
| BR112020009737A2 (en) * | 2017-11-16 | 2020-10-13 | Amgen Inc. | stable compositions of pegylated carfilzomib compounds |
| WO2021209947A1 (en) * | 2020-04-15 | 2021-10-21 | Kashiv Biosciences, Llc | Stable ready to dilute formulations of carfilzomib |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0215355B1 (en) | 1985-08-31 | 1994-04-06 | Kitasato Kenkyusho | Erythromycin derivative and process for preparing the same |
| US5133974A (en) | 1989-05-05 | 1992-07-28 | Kv Pharmaceutical Company | Extended release pharmaceutical formulations |
| US20040170724A1 (en) | 2003-02-28 | 2004-09-02 | Kraft Foods Holdings, Inc. | Mineral complexes of lactobionic acid and method of using for mineral fortification of food products |
| CN1921772B (en) | 2004-02-23 | 2012-02-22 | 诺维信公司 | Meat based food product comprising lactobionic acid |
| DK1819353T3 (en) | 2004-12-07 | 2011-05-16 | Proteolix Inc | Composition for proteasome inhibition |
| US7589106B2 (en) | 2006-09-27 | 2009-09-15 | Eagle Pharmaceuticals, Inc. | Alcohol free formulation of argatroban |
| KR20100088664A (en) * | 2007-10-04 | 2010-08-10 | 오닉스 세라퓨틱스, 인크. | Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides |
| CN101624412B (en) | 2008-07-10 | 2012-07-04 | 刘力 | Derivative of macrolides, method for preparing same and application thereof |
| US8263578B2 (en) | 2010-03-18 | 2012-09-11 | Innopharma, Inc. | Stable bortezomib formulations |
| EA201390144A1 (en) * | 2010-08-20 | 2013-06-28 | Серулин Фарма Инк. | CONJUGATES THERAPEUTIC PEPTIDE POLYMER, PARTICLES, COMPOSITIONS AND RELATED METHODS |
| WO2013112601A1 (en) | 2012-01-24 | 2013-08-01 | Millennium Pharmaceuticals, Inc. | Methods of treatment of cancer |
| FI3922241T3 (en) * | 2013-02-01 | 2023-11-28 | Celator Pharmaceuticals Inc | Remote loading of sparingly water-soluble drugs into liposomes |
-
2013
- 2013-09-10 US US14/023,247 patent/US9636376B2/en not_active Expired - Fee Related
-
2014
- 2014-09-05 SG SG10201902826PA patent/SG10201902826PA/en unknown
- 2014-09-05 SG SG11201605825WA patent/SG11201605825WA/en unknown
- 2014-09-05 EA EA201691358A patent/EA201691358A1/en unknown
- 2014-09-05 EP EP14844186.8A patent/EP3062883A4/en not_active Withdrawn
- 2014-09-05 CA CA2934859A patent/CA2934859A1/en not_active Abandoned
- 2014-09-05 WO PCT/US2014/054283 patent/WO2015038431A1/en active Application Filing
-
2016
- 2016-06-14 ZA ZA2016/04055A patent/ZA201604055B/en unknown
-
2017
- 2017-04-04 US US15/478,472 patent/US20170202901A1/en not_active Abandoned
-
2018
- 2018-09-07 US US16/124,642 patent/US20190060393A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP3062883A1 (en) | 2016-09-07 |
| WO2015038431A1 (en) | 2015-03-19 |
| US20140073583A1 (en) | 2014-03-13 |
| US9636376B2 (en) | 2017-05-02 |
| SG10201902826PA (en) | 2019-04-29 |
| US20190060393A1 (en) | 2019-02-28 |
| EA201691358A1 (en) | 2016-11-30 |
| EP3062883A4 (en) | 2017-08-16 |
| US20170202901A1 (en) | 2017-07-20 |
| ZA201604055B (en) | 2018-11-28 |
| CA2934859A1 (en) | 2015-03-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1255605A1 (en) | Enhanced stability of novel liquid compositions | |
| IL283012A (en) | Delayed release compositions of linaclotide | |
| IL244850A0 (en) | Stabilized efinaconazole compositions and uses thereof | |
| ZA201604055B (en) | Stable compositions of peptide epoxy ketones | |
| ZA201505966B (en) | Peptides and compositions | |
| SG11201506876XA (en) | Modification of polypeptides | |
| EP2968108A4 (en) | Cosmetic compositions | |
| GB201303771D0 (en) | Nanoparticles peptide compositions | |
| HK1211312A1 (en) | Epoxy siloxane coating compositions | |
| HK1220697A1 (en) | Peptide compositions | |
| EP2994507A4 (en) | Epoxy resin compositions | |
| PT3205683T (en) | Compositions and devices of poly-4-hydroxybutyrate | |
| GB201314284D0 (en) | Cosmetic compositions containing silicones | |
| PL3063152T3 (en) | Convenient preparation of n-substituted morphinan-6-ols from morphinan-6-ones | |
| IL244537A0 (en) | Novel delivery compositions and methods of using same | |
| HRP20182110T1 (en) | Composition of tiacumicin compounds | |
| GB2535880B (en) | Two-part set-delayed cement compositions | |
| IL244956B (en) | Novel peptide compositions | |
| KR102216470B9 (en) | Composition of Natural Substance | |
| PL3071575T3 (en) | Preparation of normorphinans | |
| GB201315461D0 (en) | Composition of phosphonates | |
| GB201304608D0 (en) | BenTime of Yisrael operable arrangement |